CVS GROUP
CVS GROUP operates in Diversified Metals & Mining.
CVS GROUP (4C9) - Net Assets
Latest net assets as of June 2024: €260.50 Million EUR
Based on the latest financial reports, CVS GROUP (4C9) has net assets worth €260.50 Million EUR as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€690.00 Million) and total liabilities (€429.50 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €260.50 Million |
| % of Total Assets | 37.75% |
| Annual Growth Rate | 24.0% |
| 5-Year Change | 56.36% |
| 10-Year Change | N/A |
| Growth Volatility | 33.13 |
CVS GROUP - Net Assets Trend (2016–2024)
This chart illustrates how CVS GROUP's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for CVS GROUP (2016–2024)
The table below shows the annual net assets of CVS GROUP from 2016 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-06-30 | €260.50 Million | +1.36% |
| 2023-06-30 | €257.00 Million | +18.22% |
| 2022-06-30 | €217.40 Million | +13.76% |
| 2021-06-30 | €191.10 Million | +14.71% |
| 2020-06-30 | €166.60 Million | +2.15% |
| 2019-06-30 | €163.10 Million | +3.42% |
| 2018-06-30 | €157.70 Million | +79.20% |
| 2017-06-30 | €88.00 Million | +88.84% |
| 2016-06-30 | €46.60 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to CVS GROUP's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 116.6% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (June 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €211.20 Million | 81.11% |
| Other Components | €49.20 Million | 18.89% |
| Total Equity | €260.40 Million | 100.00% |
CVS GROUP Competitors by Market Cap
The table below lists competitors of CVS GROUP ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
PT Perma Plasindo Tbk
JK:BINO
|
$144.58K |
|
MINEBEA (MEA.SG)
STU:MEA
|
$144.60K |
|
RACL Geartech Limited
NSE:RACLGEAR
|
$144.64K |
|
AXON PARTNERS GRP EO -10
F:XE1
|
$144.64K |
|
Seelos Therapeutics Inc
OTCQB:SEEL
|
$144.49K |
|
SECURITAS -B- (S7MB.SG)
STU:S7MB
|
$144.43K |
|
KYOCERA
MU:KYR
|
$144.36K |
|
SFC ENERGY - Dusseldorf Stock Exchang
DU:F3C
|
$144.35K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CVS GROUP's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 257,000,000 to 260,400,000, a change of 3,400,000 (1.3%).
- Net income of 6,200,000 contributed positively to equity growth.
- Dividend payments of 5,400,000 reduced retained earnings.
- Share repurchases of 900,000 reduced equity.
- New share issuances of 2,400,000 increased equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €6.20 Million | +2.38% |
| Dividends Paid | €5.40 Million | -2.07% |
| Share Repurchases | €900.00K | -0.35% |
| Share Issuances | €2.40 Million | +0.92% |
| Other Changes | €1.10 Million | +0.42% |
| Total Change | €- | 1.32% |
Book Value vs Market Value Analysis
This analysis compares CVS GROUP's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.99x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 10.53x to 3.99x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-06-30 | €1.38 | €14.50 | x |
| 2018-06-30 | €2.24 | €14.50 | x |
| 2019-06-30 | €2.31 | €14.50 | x |
| 2020-06-30 | €2.36 | €14.50 | x |
| 2021-06-30 | €2.70 | €14.50 | x |
| 2022-06-30 | €3.06 | €14.50 | x |
| 2023-06-30 | €3.60 | €14.50 | x |
| 2024-06-30 | €3.63 | €14.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CVS GROUP utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.38%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.96%
- • Asset Turnover: 0.94x
- • Equity Multiplier: 2.65x
- Recent ROE (2.38%) is below the historical average (9.33%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 15.02% | 3.21% | 1.06x | 4.43x | €2.34 Million |
| 2017 | 13.07% | 4.23% | 1.03x | 2.99x | €2.70 Million |
| 2018 | 6.79% | 3.27% | 1.03x | 2.02x | €-5.07 Million |
| 2019 | 5.03% | 2.02% | 1.08x | 2.31x | €-8.11 Million |
| 2020 | 3.42% | 1.33% | 0.92x | 2.79x | €-10.96 Million |
| 2021 | 10.10% | 3.78% | 1.05x | 2.54x | €190.00K |
| 2022 | 11.82% | 4.64% | 1.07x | 2.38x | €3.96 Million |
| 2023 | 16.30% | 7.11% | 1.03x | 2.23x | €16.20 Million |
| 2024 | 2.38% | 0.96% | 0.94x | 2.65x | €-19.84 Million |
Industry Comparison
This section compares CVS GROUP's net assets metrics with peer companies in the Other industry.
Industry Context
- Industry: Other
- Average net assets among peers: $114,212,818,724
- Average return on equity (ROE) among peers: -9.08%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CVS GROUP (4C9) | €260.50 Million | 15.02% | 1.65x | $144.49K |
| HORIBA (01H) | $204.49 Billion | 10.42% | 0.82x | $989.01K |
| Tokyu Corporation (01T) | $779.37 Billion | 3.34% | 2.35x | $99.73K |
| GUANGZHOU AUTO -H- (02G) | $122.28 Billion | 6.59% | 0.55x | $4.05K |
| MOSAIC (02M) | $10.60 Billion | 4.43% | 0.90x | $280.83K |
| MOSAIC (02M.SG) (02M) | $9.56 Billion | 10.46% | 0.82x | $247.21K |
| CHINA JO-JO DRGSTRS (04CN.SG) (04CN) | $16.67 Million | -126.83% | 4.46x | $1.55 Million |
| KRAKATAU STEEL -B- (07K) | $552.59 Million | 3.52% | 4.72x | $166.99 |
| CN MODERN DAIRY (07M) | $7.12 Billion | -10.42% | 1.50x | $1.68K |
| TOURMALINE OIL (08T) | $7.22 Billion | 4.81% | 0.41x | $381.02K |
| ASIA CASSAVA RESOUR (0ACS) | $913.15 Million | 2.86% | 1.55x | $325.03 |